[1] |
Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis⁃like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis[J]. Clin Rheumatol, 2009, 28(8): 979⁃984. DOI: 10.1007/s10067⁃009⁃1152⁃9.<br />
|
[2] |
Lundberg IE. The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies[J]. Curr Rheumatol Rep, 2000, 2(3): 216⁃224.<br />
|
[3] |
曹华, 夏群力, 亢延卿, 等. 抗黑素瘤分化相关基因5抗体评价皮肌炎/临床无肌病性皮肌炎合并肺间质病变的病情及预后的研究[J]. 中华风湿病学杂志, 2014, 18(5): 329⁃331. DOI: 10.3760/cma.j.issn.1007⁃7480.2014.05.009.<br />
|
[4] |
曹华, 李霞, 亢延卿, 等. 皮肌炎/临床无肌病性皮肌炎患者血清中CADM⁃140抗体的检测和临床意义[J]. 中华皮肤科杂志, 2011, 44(7): 461⁃464. DOI: 10.3760/cma.j.issn.0412⁃4030.2011. 07.001.<br />
|
[5] |
Gono T, Kaneko H, Kawaguchi Y, et al. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease[J]. Rheumatology (Oxford), 2014, 53(12): 2196⁃2203. DOI: 10.1093/rheumatology/ keu258.<br />
|
[6] |
Sun WC, Sun YC, Lin H, et al. Dysregulation of the type I interferon system in adult⁃onset clinically amyopathic dermato⁃myositis has a potential contribution to the development of interstitial lung disease[J]. Br J Dermatol, 2012, 167(6): 1236⁃1244. DOI: 10.1111/j.1365⁃2133.2012.11145.x.<br />
|
[7] |
Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts)[J]. N Engl J Med, 1975, 292(7): 344⁃347. DOI: 10.1056/NEJM197502132920706.<br />
|
[8] |
Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis[J]. Curr Opin Rheumatol, 1999, 11(6): 475⁃482.<br />
|
[9] |
Gono T, Kawaguchi Y, Hara M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis[J]. Rheumatology (Oxford), 2010, 49(7): 1354⁃1360. DOI: 10.1093/rheumatology/keq073.<br />
|
[10] |
刁立诚, 陈梦雅, 陆怡德, 等. 特发性炎症性肌病患者血清铁蛋白的检测及临床意义[J]. 中华皮肤科杂志, 2016, 49(6): 391⁃395. DOI: 10.3760/cma.j.issn.0412⁃4030.2016.06.006.<br />
|
[11] |
Caproni M, Torchia D, Cardinali C, et al. Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis[J]. Br J Dermatol, 2004, 151(4): 784⁃791. DOI: 10.1111/j.1365⁃2133.2004.06144.x.<br />
|
[12] |
Cao H, Xia Q, Pan M, et al. Gottronp papules and Gottron sign with ulceration: a distinctive cutaneous feature in a subset of patients with classic dermatomyositis and clinically amyopathic dermatomyositis[J]. J Rheumatol, 2016, 43(9): 1735⁃1742. DOI: 10.3899/jrheum.160024.<br />
|
[13] |
Tucci M, Quatraro C, Dammacco F, et al. Interleukin⁃18 over⁃ as a hallmark of the activity of autoimmune inflam⁃matory myopathies[J]. Clin Exp Immunol, 2006, 146(1): 21⁃31. DOI: 10.1111/j.1365⁃2249.2006.03180.x.<br />
|
[14] |
Kuryliszyn⁃Moskal A, Dubicki A, Zarzycki W, et al. Microvas⁃cular abnormalities in capillaroscopy correlate with higher serum IL⁃18 and sE⁃selectin levels in patients with type 1 diabetes complicated by microangiopathy[J]. Folia Histochem Cytobiol, 2011, 49(1): 104⁃110. DOI: 10.5603/FHC.2011.0015.<br />
|
[15] |
陈梦雅, 郑捷, 曹华. 皮肌炎皮损评分方法的临床应用[J]. 中华皮肤科杂志, 2017, 50(1): 70⁃72. DOI: 10.3760/cma.j.issn. 0412⁃4030.2017.01.026.<br />
|
[16] |
Bilgic H, Ytterberg SR, Amin S, et al. Interleukin⁃6 and type I interferon⁃regulated genes and chemokines mark disease activity in dermatomyositis[J]. Arthritis Rheum, 2009, 60(11): 3436⁃3446. DOI: 10.1002/art.24936.<br />
|
[17] |
Nara M, Komatsuda A, Omokawa A, et al. Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease[J]. Mod Rheumatol, 2014, 24(4): 633⁃636. DOI: 10.3109/14397595.2013.844390.<br />
|
[18] |
Gono T, Kawaguchi Y, Sugiura T, et al. Interleukin⁃18 is a key mediator in dermatomyositis: potential contribution to develop⁃ment of interstitial lung disease[J]. Rheumatology (Oxford), 2010, 49(10): 1878⁃1881. DOI: 10.1093/rheumatology/keq196.<br />
|
[19] |
Kawasumi H, Gono T, Kawaguchi Y, et al. IL⁃6, IL⁃8, and IL⁃10 are associated with hyperferritinemia in rapidly progressive interstitial lung disease with polymyositis/dermatomyositis[J]. Biomed Res Int, 2014, 2014: 815245. DOI: 10.1155/2014/815245.<br />
|
[20] |
Dalakas MC. Inflammatory muscle diseases[J]. N Engl J Med, 2015, 372(18): 1734⁃1747. DOI: 10.1056/NEJMra1402225.<br />
|